Single injection of Elonva would replace 7 daily injections

Alexandria Real Estate, a US-based life science solutions provider, is planning to set up  industry, has decided to set up a Rs 500 crore biotech research and development (R&D) and incubation facility in Sanand, in Gujarat, western India.

Oncophage cancer vaccine (Vitespen) to treat recurrent brain cancer glioma has shown encouraging results in clinical studies, Antigenics said.

Cadila Pharma, Serum Institute are also in race to launch H1N1 swine flu vaccine in next 4 months

Pegylated interferon lambda 1a (also called IL-29) has fewer side-effects compared to its close cousin pegylated interferon alfa, besides higher level activity against hepatitis C virus infection, said developers of the drug Bristol-Myers Squibb and ZymoGenetics.

Velaglucerase alfa, an enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease, has been granted priority review by the United States Food and Drug Administration, maker of the drug Shire plc announced.

NicVAX may also be effective in preventing smoking relapse

JVRS-100, a seasonal influenza vaccine for the elderly from Juvaris BioTherapeutics, Inc is currently undergoing human studies. Juvaris BioTherapeutics, Inc has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population. “There is a significant need to ...

Provenge (sipuleucel-T), a vaccine to treat prostate cancer from Dendreon Corporation may reach market within a year's time.

Alteplace was considered effective only within 3 three hours after attack